Myelodysplastic syndrome in type 1 Gaucher disease.

被引：0
|
作者：
Ruchlemer, R
Elstein, D
Meytes, D
Rachmilewitz, E
Mittelman, M
Zimran, A
机构：
[1] Shaare Zedek Hosp, Jerusalem, Israel
[2] Wolfson Med Ctr, Holon, Israel
[3] Hasharon Hosp, IL-49372 Petah Tiqwa, Israel
[4] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4871
引用
收藏
页码：263B / 263B
页数：1
相关论文
共 50 条
  • [11] Correlation between Bone Disease and Genotype in Patients with Type 1 Gaucher Disease. Data from the Spanish Gaucher Disease Registry
    Andrade-Campos, Marcio
    Irun, Pilar
    Roca-Espiau, Mercedes
    Giraldo, Pilar
    BLOOD, 2017, 130
  • [12] High prevalence of gallstones and abnormal lipid metabolism in type 1 Gaucher disease.
    Mistry, PK
    Hyogo, H
    Lomazow, W
    Lim, K
    Chung, H
    Deng, HT
    Hermann, G
    Wallerstein, S
    Cohen, DE
    HEPATOLOGY, 2001, 34 (04) : 208A - 208A
  • [13] Immune and autoimmune phenomena in type I Gaucher disease.
    Rosenbaum, H
    Hoffman, R
    Brenner, B
    Rowe, JM
    BLOOD, 2002, 100 (11) : 41B - 41B
  • [14] Mesenteric mass associated with type III Gaucher disease.
    Rhead, WJ
    Camitta, B
    Margolis, D
    Hernanz-Schulman, M
    Dudek, ME
    Tiller, GE
    MOLECULAR GENETICS AND METABOLISM, 2005, 84 (03) : 238 - 238
  • [15] Coexistence of Gaucher disease type 1 and Joubert syndrome - Reply
    Van Royen-Kerkhof, A
    Poll-The, BT
    Beemer, FA
    JOURNAL OF MEDICAL GENETICS, 1999, 36 (11) : 871 - 871
  • [16] Adult Gaucher disease.
    Stirnemann, J
    Belmatoug, N
    REVUE DE MEDECINE INTERNE, 2001, 22 : 374S - 383S
  • [17] Intermediate phenotype between type II and type III Gaucher disease.
    Krishnamurthy, V
    McDonald, M
    Hanna, R
    Mackay, J
    Kishnani, P
    GENETICS IN MEDICINE, 2004, 6 (04) : 276 - 276
  • [18] Short-term effect of oral treatment with miglustat in type 1 Gaucher disease.
    Giraldo, P
    Alonso, D
    Acedo, M
    Franco, R
    Barez, A
    Corrales, A
    Serrano, D
    Roldan, V
    Latre, P
    Alfonso, P
    Pocovi, M
    BLOOD, 2005, 106 (11) : 629A - 630A
  • [19] Effect of enzyme replacement therapy on bone mineral density in type 1 Gaucher disease.
    Wenstrup, R
    Kacena, K
    Kaplan, P
    Pastores, G
    Prakash-Cheng, A
    Zimran, A
    Hangartner, T
    BLOOD, 2005, 106 (11) : 54B - 54B
  • [20] Subtle neuropsychological abnormalities in patients with type I Gaucher disease.
    Elstein, D
    Guedalia, J
    Rosenberg, P
    Antebi, V
    Arnon, Y
    Zimran, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 449 - 449
12345